Abboud H, Berroir S, Labreuche J, et al.

Insular involvement in brain infarction

increases risk for cardiac arrhythmia and death. Ann Neurol 2006;59:691-699

Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy
for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and
Thrombolytic Therapy. Chest 2004;126:483S-512S.

Al-Zaiti SS, Magdic KS. Paroxysmal supraventricular tachycardia: pathophysiology,

diagnosis, and management. Crit Care Nurs Clin North Am 2016;28:309-316.

Biller J, Love BB, Schneck MJ. Vascular diseases of the nervous system ischemic
cerebrovascular disease. In: Daroff RB, Fenichel GM, Jankovic J, eds. Bradley’s
neurology in clinical practice. 6th ed. Philadelphia (PA): Elsevier/Saunders,
2012:1003-1016.

Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines

for the management of patients with supraventricular arrhythmias—executive summary: a
report of the American College of Cardiology/American Heart Association Task Force on
Practice Guidelines and the European Society of Cardiology Committee for Practice
Guidelines (Writing Committee to Develop Guidelines for the Management of Patients
With Supraventricular Arrhythmias). Circulation 2003;108:1871-1909.

Burhanuddin, M. 2012. Faktor Risiko Kejadian Stroke Pada Dewasa Awal (18-40
Tahun) di kota Makasar tahun 2010-2012. Bagian Epidemiologi FKM UNHAS, 1-14.

Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways,

atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final
results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators
Group. Circulation 1999;99:262- 270.

Casado-Arroyo R, Gargallo C, Lanas Arbeloa A. Balancing the risk and benefits of

low-dose aspirin in clinical practice. Best Pract Res Clin Gastroenterol
2012;26:173-184.

Chen CY, Lee KT, Lee CT, et al. Effectiveness and safety of antiplatelet in stroke
patients with end-stage renal disease undergoing dialysis. Int J Stroke
2014;9:580-590.
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention
of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.

Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of

death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various
categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994;308:81-106.

De Jong G, van Raak L, Kessels F, et al. Stroke subtype and mortality. A follow-up
study in 998 patients with a first cerebral infarct. J Clin Epidemiol 2003;56:262-268.

Desmond, P.M., Tress, B.M., et al. Persistent postroke hyperglicemia is

independently associated with infarct expansion and worse clinical outcome. Stroke.
2007 September; 34(9):2208-14. Beckman, J.A., Creager, M.A., Libby, P.,et al.
Diabetes and Atherosclerosis Epidemiology, Pathophysiology, and Management.
JAMA. 2002 ;287 (19): 2570-2581).

Dewi. 2016. Jenis-Jenis Stroke. Retrieved from

http://poliklinik.idpdn.ac.id/home/artikel-kesehatan/jenis-jenis-stroke.

Eastern Stroke Coronary Heart Disease Collaborative Research. Blood pressure,

cholestrol, and stroke in eastern Asia Lancert 1998; 352:1801-7.

Falcone G.J et al. 2013. Predictors of Hematoma Volume in Deep and Lobar
Supratentorial Intracerebral Hemorrhage. JAMA Neurology. 70:(8).

Flaherty M et al. 2010. The Epidemiology of Intracerebral Hemorrhage. Cambridge

University Press.

Hull, A. 2005. Penyakit Jantung Hipertensi dan Nutrisi. Terjemahan oleh Wendra Ali.
Jakarta : Bumi Aksara, Hal. 22-26.

Hu Y.Z et al. 2013. Epidemiological and Clinical Characteristic of Cases of

Intracerebral Hemorrhage in Hangzhou, China. Journal of Zhejiang University
Sciences B. 1456: 496-504.
Ikram M.A et al. 2012. International Epidemiology of Intracerebral Hemorrhage.
Curent Atherosclerosis Rep. Sringer Journal. 14: 300-306.

Jolink W.M et al. 2015. Time Trends in Incidence, Case Fatality, and Mortality of
Intracerebral Hemorrhage. Journal Neurology. 85:1318-1324.

Kamel H, Elkind MS, Bhave PD, et al. Paroxysmal supraventricular tachycardia and
the risk of ischemic stroke. Stroke 2013;44:1550-1554

LIPI. UPT-Balai Informasi Teknologi LIPI. 2009. Retrieved from

http://www.bit.lipi.go.id/pangan-kesehatan/documents/articel-hipertensi/hipertensi.pd
f.

Lee M, Saver Jl, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low glomerular
filtration rate and risk of stroke; metaanalysis. BMJ 2010; 341: 4249.

Liu J et al. 2011. Hyperglicemia Induced Cerebral Hematoma Expansion is mediated

by Plasma Kallikrein. National Medical Journal. 17(2):206-210.

Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to

mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative
classification system: direct comparison in the North Dublin population stroke study.
Stroke 2010;41:1579-1586.

Ministry of Health and Welfare. Table 3. causes of death over the years [in Chinese].
Available at: http:// www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no
=312&fod_list_no=5488. Accessed September 5, 2015.

Nakayama M, metoki H, Terawaki H, Okhubo T, Kikuya M, Sato T, et al. Kidney

dysfunction as a risk factor for first symptomatic stroke events in a general Japanese
population-the Ohasama study. Nephrol Dial Transplant 2007; 22: 1910-5.

Nickolas TL, Khatri M, Boden-Albala B, Kiryluk K, Luo X, Gervasi-Franklin P, et al.

The association between kidney disease and cardiovascular risk in a multiethnic
cohort: findings from the Northern Manhattan Study (NOMAS). Stroke
2008;39:2876-9.
Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, et al. Impact of
kidney disease and blood pressure on the development of cardiovascular disease: an
overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008; 118:
2694-701.

Nastiti, D. 2012. Gambaran Faktor Risiko Kejadian Stroke Pada Pasien Rawat Inap
di Rumah Sakit Krakatau Medika Tahun 2011. Universitas Indonesia.

Orejarena LA, Vidaillet H Jr, DeStefano F, et al. Paroxysmal supraventricular

tachycardia in the general population. J Am Coll Cardiol 1998;31:150-157.

Perdossi. 2011. Kelompok Studi Stroke. Stroke Aspek Diagnostic, Patofisiologi,

Manajemen. Jakarta : PERDOSI.

Qureshi a.I et al. 2011. Association of Serum Glucose Concentration during Acute
Hospitalization whit hematom Expansion. Perihematomal Edem and Three Month
Outcome among Patients with Intracerebral Hemorrhage. Journal Neurotrical Care.
15(3): 428-35.

Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012
update: a report from the American Heart Association. Circulation 2012;125: e2-e220.

Salihovic Det al. 2013. Does the Volume and Localization of Intracerebral Hematoma
Affect Short-Term Prognosis of patients With Intracerebral Hemorrhage. ISRN
Neuroscience.

Setyopranoto, Ismail. 2011. Continuing Medical Education. CDK 185 Vol. 38 No. 4.
Yogyakarta: Unit Stroke RSUP Dr.

Sheps, Sheldon G. 2005. Mayo Clinic Hipertensi, Mengatasi Tekanan Darah Tinggi.
Jakarta : PT Intisari Mediatama.

Wannamethee, S. Goya, Shaper, A. Gerald, Ebrahim, S. 2000. HDL-Cholestrol, Total

Cholestrol, and the Risk of Stroke in Middle-Aged British Men. American Heart
Association, Inc. All rights reserved.
Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular
tachycardia presenting with aborted sudden death: incidence, mechanism and
long-term follow-up. J Am Coll Cardiol 1991;18:1711-1719.

Wafarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke

Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.

Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in

supraventricular tachycardia. Am J Cardiol 1997;79:145-149.

World Health Organization. 2010. Global Burden of Stroke. Available

from:http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf

Wu EB, Chia HM, Gill JS. Reversible cardiomyopathy after radiofrequency ablation
of lateral free-wall pathway- mediated incessant supraventricular tachycardia. Pacing
Clin Electrophysiol 2000;23:1308-1310.